Tobias Homan1, Alexandra Hiscox1, Collins K Mweresa2, Daniel Masiga2, Wolfgang R Mukabana3, Prisca Oria4, Nicolas Maire5, Aurelio Di Pasquale5, Mariabeth Silkey5, Jane Alaii6, Teun Bousema7, Cees Leeuwis8, Thomas A Smith5, Willem Takken9. 1. Laboratory of Entomology, Wageningen University and Research Centre, Wageningen, Netherlands. 2. International Centre of Insect Physiology and Ecology, Nairobi, Kenya. 3. School of Biological Sciences, University of Nairobi, Nairobi, Kenya. 4. Knowledge, Technology, and Innovation Group, Wageningen University and Research Centre, Wageningen, Netherlands; International Centre of Insect Physiology and Ecology, Nairobi, Kenya. 5. Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland. 6. Context Factor Solutions, Nairobi, Kenya. 7. Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, Netherlands. 8. Knowledge, Technology, and Innovation Group, Wageningen University and Research Centre, Wageningen, Netherlands. 9. Laboratory of Entomology, Wageningen University and Research Centre, Wageningen, Netherlands. Electronic address: willem.takken@wur.nl.
Abstract
BACKGROUND: Odour baits can attract host-seeking Anopheles mosquitoes indoors and outdoors. We assessed the effects of mass deployment of odour-baited traps on malaria transmission and disease burden. METHODS: We installed solar-powered odour-baited mosquito trapping systems (SMoTS) to households on Rusinga Island, Lake Victoria, western Kenya (mean population 24 879), in a stepped-wedge cluster-randomised trial. All residents in the completed health and demographic surveillance system were eligible to participate. We used the travelling salesman algorithm to assign all households to a cluster (50 or 51 geographically contiguous households); nine contiguous clusters formed a metacluster. Initially, no cluster had SMoTS (non-intervened). During the course of the intervention roll-out SMoTS were gradually installed cluster by cluster until all clusters had SMoTS installed (intervened). We generated 27 cluster randomisations, with the cluster as unit of randomisation, to establish the order to install the traps in the clusters until all had a SMoTS installed. Field workers and participants were not masked to group allocation. The primary outcome of clinical malaria was monitored through repeated household visits covering the entire population, once before roll-out (baseline) and five times throughout the 2-year roll-out. We measured clinical malaria as fever plus a positive result with a rapid diagnostic test. The SolarMal project was registered on the Dutch Trial Register (NTR 3496). FINDINGS:We enrolled 34 041 participants between April 25, 2012, and March 23, 2015, to 81 clusters and nine metaclusters. 4358 households were provided with SMoTS during roll-out between June 3, 2013, and May 16, 2015. 23 clinical malaria episodes were recorded in intervened clusters and 33 episodes in non-intervened clusters (adjusted effectiveness 40·8% [95% CI -172·8 to 87·1], p=0·5) during the roll-out. Malaria prevalence measured by rapid diagnostic test was 29·8% (95% CI 20·9-38·0) lower in SMoTS clusters (prevalence 23·7%; 1552 of 6550 people) than in non-intervened clusters (prevalence 34·5%; 2002 of 5795 people). INTERPRETATION: The unexpectedly low clinical incidence of malaria during roll-out led to an imprecise estimate of effectiveness from the clinical incidence data. The substantial effect on malaria prevalence is explained by reduction in densities of Anopheles funestus. Odour-baited traps might be an effective malaria intervention. FUNDING: COmON Foundation.
RCT Entities:
BACKGROUND: Odour baits can attract host-seeking Anopheles mosquitoes indoors and outdoors. We assessed the effects of mass deployment of odour-baited traps on malaria transmission and disease burden. METHODS: We installed solar-powered odour-baited mosquito trapping systems (SMoTS) to households on Rusinga Island, Lake Victoria, western Kenya (mean population 24 879), in a stepped-wedge cluster-randomised trial. All residents in the completed health and demographic surveillance system were eligible to participate. We used the travelling salesman algorithm to assign all households to a cluster (50 or 51 geographically contiguous households); nine contiguous clusters formed a metacluster. Initially, no cluster had SMoTS (non-intervened). During the course of the intervention roll-out SMoTS were gradually installed cluster by cluster until all clusters had SMoTS installed (intervened). We generated 27 cluster randomisations, with the cluster as unit of randomisation, to establish the order to install the traps in the clusters until all had a SMoTS installed. Field workers and participants were not masked to group allocation. The primary outcome of clinical malaria was monitored through repeated household visits covering the entire population, once before roll-out (baseline) and five times throughout the 2-year roll-out. We measured clinical malaria as fever plus a positive result with a rapid diagnostic test. The SolarMal project was registered on the Dutch Trial Register (NTR 3496). FINDINGS: We enrolled 34 041 participants between April 25, 2012, and March 23, 2015, to 81 clusters and nine metaclusters. 4358 households were provided with SMoTS during roll-out between June 3, 2013, and May 16, 2015. 23 clinical malaria episodes were recorded in intervened clusters and 33 episodes in non-intervened clusters (adjusted effectiveness 40·8% [95% CI -172·8 to 87·1], p=0·5) during the roll-out. Malaria prevalence measured by rapid diagnostic test was 29·8% (95% CI 20·9-38·0) lower in SMoTS clusters (prevalence 23·7%; 1552 of 6550 people) than in non-intervened clusters (prevalence 34·5%; 2002 of 5795 people). INTERPRETATION: The unexpectedly low clinical incidence of malaria during roll-out led to an imprecise estimate of effectiveness from the clinical incidence data. The substantial effect on malaria prevalence is explained by reduction in densities of Anopheles funestus. Odour-baited traps might be an effective malaria intervention. FUNDING: COmON Foundation.
Authors: Chad L Schaber; Nalin Katta; Lucy B Bollinger; Mwawi Mwale; Rachel Mlotha-Mitole; Indi Trehan; Barani Raman; Audrey R Odom John Journal: J Infect Dis Date: 2018-04-23 Impact factor: 5.226
Authors: Robert T Jones; Elizabeth Pretorius; Thomas H Ant; John Bradley; Anna Last; James G Logan Journal: Philos Trans R Soc Lond B Biol Sci Date: 2020-12-28 Impact factor: 6.237
Authors: Jetske G de Boer; Ailie Robinson; Stephen J Powers; Saskia L G E Burgers; John C Caulfield; Michael A Birkett; Renate C Smallegange; Perry J J van Genderen; Teun Bousema; Robert W Sauerwein; John A Pickett; Willem Takken; James G Logan Journal: Sci Rep Date: 2017-08-24 Impact factor: 4.379
Authors: Monicah M Mburu; Collins K Mweresa; Philemon Omusula; Alexandra Hiscox; Willem Takken; Wolfgang R Mukabana Journal: Malar J Date: 2017-08-24 Impact factor: 2.979
Authors: Ailie Robinson; Jack Bickford-Smith; Oumer Abdurahman Shafi; Muluadam Abraham Aga; Gemeda Shuka; Dereje Debela; Gebreyes Hordofa; Wondu Alemayehu; Virginia Sarah; Anna Last; David MacLeod; Matthew J Burton; James G Logan Journal: Sci Rep Date: 2021-07-09 Impact factor: 4.379